Business / Finance

RSS

Sino Biological, Inc. to be featured on worldwide business with Kathy Ireland®

Sino Biological, Inc.a biotechnology company which provides biological research reagents and related technical contract research services

From Sino Biological Inc. 19 Oct 2021

Acquisition of Advanced Diagnostic Laboratory LLC

ADL Health’s CLIA-certified laboratory covers the fields of clinical, forensic and microbiological tests.

From EKF Diagnostics 11 Oct 2021

Owlstone Medical appoints Mark Capone to board of directors

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the appointment of Mark Capone, former President and CEO of Myriad Genetics to its Board as an independent non-executive director.

From Owlstone Medical Ltd 17 Sep 2021

Curia to expand U.S. commercial manufacturing capability

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced plans to expand its commercial manufacturing capacity at its Rensselaer, New York facility.

From Curia 23 Aug 2021

Purisys Adds ISO Certifications Confirming Its Commitment to Quality and Excellence

Purisys LLC, a leading supplier of active pharmaceutical ingredients (APIs), contract development and manufacturing (CDMO) services, and pharmaceutical reference materials, today announced that it has obtained two additional global ISO certifications: ISO 17025 (Testing and Calibration Laboratories) and ISO 17034 (Reference Materials Producers).

From Purisys 9 Jul 2021

Nikalyte Announces New Partnership with Life Science Group Calibre Scientific

Nanoparticle deposition specialists, Nikalyte Ltd announced that the company has signed a partnership agreement with global life sciences group Calibre Scientific.

From Nikalyte Ltd 8 Jul 2021

PerkinElmer to buy SIRION Biotech

PerkinElmer Inc. agreed to buy SIRION Biotech GmbH, a provider of viral vector-based technologies that drive improved delivery performance for cell and gene therapies. The acquisition is expected to close during the third quarter of 2021.

From Revvity 24 Jun 2021

PHOTONICS+ Virtual Exhibition and Conference

PHOTONICS+ Virtual Exhibition and Conference, in partnership with EPIC (European Photonics Cluster), will take place for the second time on June 29th + 30th, 2021 at 13:00 – 17:00 CEST timezone. The soft opening of the platform is scheduled for June 8th.

From Monocrom 17 Jun 2021

European grant awarded for innovative orthopedic training simulator

June 9, 2021, Zurich, Switzerland: VirtaMed, the world leader in data-driven medical simulation training, together with the Centre Hospitalier de Luxembourg (CHL), a public hospital of Luxembourg city, will develop a mixed reality simulator to support surgical skills training for advanced arthroscopic meniscus repair.

From VirtaMed 9 Jun 2021

Iksuda Therapeutics closes $47 million financing round

Iksuda Therapeutics (Iksuda) has announced it has completed a US $47 million (circa GB £34 million) financing round, co-led by Mirae Asset Capital and its subsidiaries, Celltrion and Premier Partners, with the Company being advised by Ashfords LLP. The funding will support the advancement of Iksuda’s lead ADC assets and expansion of its payload and conjugation platform technologies.

From Iksuda Therapeutics 8 Jun 2021

ERS Genomics and genOway enter CRISPR/Cas9 agreement

ERS Genomics Limited today announced a non-exclusive license agreement granting genOway past and future access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

7 Jun 2021

VirtaMed appoints Andy Weymann, MD, MBA, to Board of Directors

June 1, 2021, Zurich, Switzerland: VirtaMed, the world leader in medical simulation training, has added Andy Weymann to its board of directors.

From VirtaMed 1 Jun 2021

Qvella Appoints Richard Brock as VP of Global Marketing and Signals Start of Commercialization

Industry veteran departs bioMérieux to lead the commercialization of Qvella’s lineup of products starting with FAST-Prep, an automated cartridge-based system for Positive Blood Culture (PBC) processing.

19 May 2021

Advantech Connect Online Partner Conference to Promote Edge-to-Cloud Partnerships and AIoT Solutions for Smart City Services

Irvine, California, April 21, 2021 - Advantech (stock code: 2395), a leading provider of advanced IoT intelligence systems, is excited to launch its Advantech Connect Online Partner Conference, an online partner conference for global partners, focusing on the theme “Edge-to-Cloud Partnerships Enable Smart City Services with AIoT”.

From Advantech 21 Apr 2021

Malvern Panalytical and concept life sciences announce integration

Malvern Panalytical, manufacturer of analytical systems, and Concept Life Sciences (Cheshire, UK), a contract research organization, have today announced a full business integration.

From Malvern Panalytical 13 Apr 2021

Simulation course increases physician confidence up to 125% while improving knowledge, cognitive and technical skills

The American Society for Reproductive Medicine (ASRM) publishes the first validation study on the ASRM Embryo Transfer Simulator, showing significant improvements in Embryo Transfer competence.

From VirtaMed 29 Mar 2021

Albumedix announces recombinant human albumin supply partnership with FUJIFILM Wako Pure Chemical Corporation for the Japanese, Chinese and Hong Kong markets

Albumedix Ltd. (‘Albumedix’), an enabler of advanced therapies and world leader in recombinant human albumin (rHA), announced today that they have entered into a distribution agreement with established and well recognized reagent supplier FUJIFILM Wako Pure Chemical Corporation (FUJIFILM Wako) in Japan and China including Hong Kong.

From Albumedix Ltd. 29 Mar 2021

Win an original PIPETBOY!

INTEGRA introduced the original PIPETBOY in 1981 to provide the best possible pipetting experience and, since then, it has gone from strength to strength.

From INTEGRA Biosciences 17 Mar 2021

INTEGRA Biosciences continues strong growth in 2020

INTEGRA Biosciences AG – based in Zizers, Switzerland and Hudson, New Hampshire – has released its 2020 annual report, with sales rising 73% compared to the previous year for this manufacturer of laboratory equipment and pipettes.

From INTEGRA Biosciences 17 Mar 2021

ERS Genomics and ZeClinics sign CRISPR/Cas9 license agreement

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and ZeClinics, a contract research organization using zebrafish to carry out services focused on analyzing the safety, efficacy and biomedical relevance of new compounds, today announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

From ZeClinics SL 16 Feb 2021